Marisa R Buchakjian, MD, PhD, FACS
Otolaryngology - Head and Neck Surgery
1500 E. Medical Center Dr.
Ann Arbor, MI 48109
Manage Your Profile
About
Dr. Buchakjian is a surgical oncology and microvascular surgeon in the Department of Otolaryngology - Head and Neck Surgery. She completed an MD/PhD at Duke University with graduate studies in Molecular Cancer Biology, and trained as a resident and T32 postdoc at the University of Iowa. After residency she joined the University of Michigan as a Head and Neck fellow, and then returned to the University of Iowa as faculty. She moved back to UM to join the Head and Neck Oncology Division in 2024. Dr. Buchakjian's clinical interests include oral cavity, oropharynx, larynx, salivary, and skin cancers. She is trained in complex microvascular free tissue transfer as well as transoral robotic surgery. She is also a member of the Rogel Comprehensive Cancer Center in the Signaling and Tumor Microenvironment Program.
Qualifications
-
Fellow, Head and Neck Surgical Oncology-Microvascular ReconstructionUniversity of Michigan, Department of Otolaryngology - Head and Neck Surgery, Ann Arbor, MI, United States
2018 - 2019
Clinical Fellowship
-
Resident, Otolaryngology - Head and Neck SurgeryUniversity of Iowa Hospitals and Clinics, Department of Otolaryngology - Head and Neck Surgery, Iowa City, IA, United States
2011 - 2018
Residency
-
Postdoctoral Fellow, Molecular Physiology and BiophysicsUniversity of Iowa - Carver College of Medicine, Iowa City, IA, United States
2012 - 2014
Postdoctoral Fellowship
-
MDDuke University School of Medicine, Durham, NC, United States
2003 - 2011
-
PhD, Molecular Cell BiologyDuke University, Durham, NC, United States
2005 - 2010
-
BA, Biology, Chemistry, and SpanishCase Western Reserve University, Cleveland, OH, United States
1999 - 2003
Research Overview
Dr. Buchakjian's research interests are centered around cellular signaling and molecular pathogenesis of oral cavity squamous cell carcinoma, with a focus on cancer cell invasion, epithelial-mesenchymal transition, and cellular metabolism. Her laboratory is currently characterizing a novel cell-based model of epithelialmesenchymal transition and is using this tool to examine modifiers of invasion, transcription factor expression, and differences in energy utilization. She has additional translational and clinical research interests focused on clinicopathologic predictors of cancer behavior and prognosis.
Recent Publications
-
Flores G, Uaroon S, Garay JAR, Vanneste M, Riordan JD, Dupuy AJ, Thiel KW, Colling KE, Stipp CS, Lin LC, Hollis B, Leidinger MR, Chen SJT, Graham LM, Knudtson KL, Chimenti MS, Ratcliff JA, Mehdi Z, McElliott MC, Anderson ER, Henry MD, Heft Neal ME, Brenner JC, Buchakjian MR. Cell Death Discovery, 2026 Dec 1; 12 (1):Journal ArticleNewly identified invasion drivers define the tumor front in oral squamous cell carcinoma
DOI:10.1038/s41420-026-03202-y -
Forner D, Pozin MA, Prince ME, Casper KA, Heft Neal ME, Buchakjian MR, Yalamanchi P. 2026 Oct 10;Proceeding / Abstract / PosterIncidence, Diagnostic Evaluation, and Healthcare Utilization Among Adults Presenting with a Cystic Neck Mass
-
Thomas EA, Liu J, Yu M, Heft Neal ME, Yalamanchi P, Buchakjian MR, Forner DWA. Oral Oncology, 2026 Oct 1; 181:Journal ArticleRural-Urban disparities in head and neck cancer mortality in the United States: Subsite-Specific Trends, 2010–2024
DOI:10.1016/j.oraloncology.2026.108111 PMID: 42585754 -
Coyle AH, Hutton DW, Buchakjian MR, Casper KA, Forner DW, Hawley ST, Heft Neal ME, Malloy KM, Mierzwa ML, Prince ME, Shah JL, Sweicicki PL, Shuman AG, Stucken CL, Veenstra CM, Worden FP, Yalamanchi P. JAMA Otolaryngology Head and Neck Surgery, 2026 Sep 1; e262124 - e262124.Journal ArticleCombined Positive Score and Cost-Effectiveness of Perioperative Pembrolizumab for Head and Neck Cancer. Epub ahead of print
DOI:10.1001/jamaoto.2026.2124 -
Adil AA, Gensterblum-Miller E, Owen JH, Buchakjian MR, Brenner CJ, Heft-Neal ME. Otolaryngology Head and Neck Surgery United States, 2026 Aug 1; 175 (2): 419 - 426.Journal ArticleHypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma
DOI:10.1002/ohn.70288 PMID: 42171285 -
Casper J, Prince A, Knill C, Lyden T, Hardenbergh A, Ambrose M, Mierzwa ML, Buchakjian M, Dave F, Prince ME, Heft-Neal ME, Yalamanchi P. International Journal of Radiation Oncology • Biology • Physics, 2026 Apr 18; 125 (1): e40 - e41.Journal ArticleAccuracy and Safety of Patient-Facing GenAI Platforms in Post-Laryngectomy Care
DOI:10.1016/j.ijrobp.2026.02.080 -
Mierzwa M, Brenner C. Journal of Molecular Diagnostics, 2026 Apr 30;Journal ArticleValidation of MyHPVscore: a high-performance HPV ctDNA lab developed test
-
Dalal PJ, Dermody SM, Ali H, Brummel C, Chad Brenner J, Buchakjian M, Casper KA, Chinn SB, Forner D, Hasan D, Malloy KM, McHugh J, Mierzwa M, Heft Neal ME, Prince ME, Shah J, Shuman AG, Stucken CL, Spector ME, Yalamanchi P, Worden FP, Swiecicki PL. Oto Open, 2026 Apr 1; 10 (2):Journal ArticleLate Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term Surveillance
DOI:10.1002/oto2.70259
Featured News & Stories